Robert Zimmerman, M.D.
| Appointed: |
2001 |
| Gender: |
Male |
| Languages: |
English |
Endocrinology, Diabetes and Metabolism
Education & Fellowships
| Medical School: | Johns Hopkins University School of Medicine, Baltimore, MD |
|
| Internship: | Duke University Medical Center, Internal Medicine, Durham, NC |
| Residency: | Duke University Medical Center, Internal Medicine, Durham, NC |
| Fellowship: | Mayo Clinic, Endocrinology, Rochester, MN |
| Other Education: | (Undergraduate) University of Michigan, Ann Arbor, MI |
Certifications
Endocrinology, Diabetes & Metabolism
Internal Medicine
Specialty Interests
Adrenal disorders, Androgen Excess, Diabetes, diabetes and diabetes complications, diabetes mellitus, endocrinology, Flushing Syndromes, Gastric Bypass Surgery, general and adolescent endocrinology, general endocrinology, growth hormone in adults, hair loss in women, Hirsutism, hirsutism thyroid disorder, hyperlipidemia, insulin resistance and cardiovascular risk prevention, Lipid Disorders, Male Infertility, Metabolic Syndrome, metabolism, multiple endocrine neoplasia syndromes, Obesity, Osteoporosis, parathyroid and calcium disorders, pituitary and adrenal disorders, pituitary disease, Prolactin Excess States, thyroid, thyroid cancers, thyroid disease, thyroid disorders, thyroid nodules, type 1 diabetes.
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 10/20/2008, Dr. Zimmerman has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Zimmerman receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- GlaxoSmithKline
- Merck & Co., Inc.
- Novartis
- Pfizer Inc.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
